biomarkers

Atrophied brain lesion volume is the sole marker from MRI scans that can accurately predict which patients with multiple sclerosis will progress to the most severe form of the disease, new research indicates. Secondary progressive MS, known as SPMS, typically appears 10 to 20 years after the initial onset and causes more physical and cognitive… Read more

Researchers have pinpointed 14 molecules in blood independently associated with dying from any cause. A score based on the molecules was able to predict risk of death over a 5- or 10-year period. The finding is especially astonishing, “given that it is only based on 14 metabolic markers in blood measured at a single point… Read more

A potential new biomarker and drug target for amyotrophic lateral sclerosis has been identified by research led by stem cell scientists at Harvard University. The study used stem cell models of human motor neurons to reveal the gene STMN2 as a potential therapeutic target, demonstrating the value of this human stem cell model approach in… Read more

A biomarker for multiple sclerosis that could be an early warning for the disease has shown promise in both human and animal testing. Researchers at Purdue University and the Indiana University School of Medicine found that acrolein, a molecule previously suspected as a metabolic waste product that accumulates in people with certain neurological disorders such… Read more

A magnetic wire used to retrieve scarce and hard-to-capture tumor cells could turn out to be a rapid and effective tactic for early cancer detection, researchers at the Stanford University School of Medicine report. The wire, which is threaded into a vein, attracts special magnetic nanoparticles engineered to glom onto tumor cells that may be… Read more